The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia Burden
When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.